Also trades as: HSCS (NASDAQ) · $vol 10M
HSCSW NASDAQ
HeartSciences Inc.
1W: +0.2%
1M: +11.9%
3M: -35.0%
YTD: -8.6%
1Y: -66.5%
$0.05
+0.00 (+5.03%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
10 relationships10
As Filer
counterparties named
0
As Counterparty
mentioned by others
2
Rel. Types
2022-06-16
Earliest Filing
2025-08-04
Latest Filing
partner: 8
investor: 2
Counterparties (Filed by HSCSW)
10 relationshipsCompanies named in HSCSW's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Maxim Group LLC | MMS | partner | Sales agent for the Company's at-the-market equity distribution agreement. | 2025-08-04 | View |
| Icahn School of Medicine at Mount Sinai | — | partner | Partnered to commercialize AI-based cardiovascular algorithms and provide ongoing cooperation. | 2023-12-06 | View |
| Icahn School of Medicine at Mount Sinai | — | partner | Partner in a securities purchase agreement and license agreement to commercialize AI-based cardiovascular algorithms. | 2023-11-17 | View |
| Maxim Group LLC | MMS | partner | Sales agent in an equity distribution agreement for the sale of common stock. | 2023-11-17 | View |
| Maxim Group LLC | MMS | partner | Sales agent for the Company's at-the-market equity distribution agreement. | 2023-11-13 | View |
| Maxim Group LLC | MMS | partner | Sales agent for the Company's at-the-market equity distribution agreement. | 2023-09-22 | View |
| Icahn School of Medicine at Mount Sinai | — | partner | Entered into license agreements and securities purchase agreement for technology licensing and equity investment. | 2023-09-21 | View |
| Lincoln Park Capital Fund, LLC | — | investor | Institutional investor entering a purchase agreement to buy up to $15.0 million worth of common stock over 36 months. | 2023-03-13 | View |
| Cavalry Investment Fund, LP | — | investor | Holder of Bridge Warrants and party to Amendment No. 1 | 2022-09-09 | View |
| The Benchmark Company, LLC | — | partner | Representative of underwriters in the IPO underwriting agreement | 2022-06-16 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-10-02 | Material Agreement; Financial Obligation; Exhibits | Agreement | View |
| 2026-09-17 | Regulation FD; Other Events; Exhibits | View | |
| 2026-09-15 | Earnings Release; Exhibits | View | |
| 2026-08-20 | Regulation FD; Exhibits | View | |
| 2026-08-19 | Regulation FD; Exhibits | View | |
| 2026-08-19 | Exhibits | View | |
| 2026-08-18 | Material Agreement; Unregistered Equity Sales; Exhibits | Agreement | View |
| 2026-08-07 | Delisting Notice | View | |
| 2026-07-29 | Earnings Release; Exhibits | View | |
| 2026-07-27 | Exhibits | View | |
| 2026-07-27 | Material Agreement; Exhibits | Agreement | View |
| 2026-07-23 | Regulation FD; Exhibits | View | |
| 2026-07-10 | Unregistered Equity Sales; Officer/Director Change; Exhibits | View | |
| 2026-06-26 | Unregistered Equity Sales; Officer/Director Change; Exhibits | View | |
| 2026-06-23 | Material Agreement; Financial Obligation; Unregistered Equity Sales; Officer/Director Change; Regula | Agreement | View |
| 2026-06-23 | Regulation FD; Exhibits | View | |
| 2026-05-06 | Shareholder Vote | View | |
| 2026-04-03 | Officer/Director Change | View | |
| 2026-03-16 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2026-01-16 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Unregistered Sale | Agreement | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR